XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.1
SCHEDULE OF ANTI-DILUTIVE IMPACT ON NET LOSSES (Details) - shares
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 361,781 3,741,331 448,031 3,569,455
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 125,531 696,955 [1] 125,531 [2] 611,017 [2]
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 236,250 322,500
Common Shares issuable upon Conversion of Convertible Notes [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 234,376 148,438
Common Shares issuable upon Conversion of Series A Preferred [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 1,500,000 1,500,000
Common Shares issuable upon Conversion of Series B Preferred [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 1,310,000 1,310,000
[1] Does not include Representative warrants issued to underwriter for 51,000, which are not exercisable until March 1, 2025.
[2] Does not include Representative warrants issued to underwriter for 51,000, which are not exercisable until March 1, 2025.